1174. Deputy Naoise Ó Muirí asked the Minister for Health if the HSE intends to add amivantamab, which has been approved by the European Medicines Agency, to the list of reimbursable medicines (details supplied); and if she will make a statement on the matter [64521/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.